Elizabeth A. Garofalo

Director · 3 filings · Latest: Jun 17, 2026

ACADIA PHARMACEUTICALS INC

Alector, Inc.

Xenon Pharmaceuticals Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
XENE	Elizabeth A. Garofalo	Director	Jun 1, 2026	Option Exercise	—	2,645	—	2,645	Jun 4 1:04 AM
ACAD	Elizabeth A. Garofalo	Director	May 29, 2026	Option Exercise	—	8,107	—	33,489	Jun 1 10:00 PM
ACAD	GAROFALO ELIZABETH A.	—	Mar 5, 2025	Proposed Sale	$18.23	4,919	$89.7K	—	Mar 6 5:17 PM